Has Paul Ruggle received payments from drug or device companies?

Yes. Drug and device makers reported $4,973 in general payments to Paul Ruggle across 378 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Ruggle did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Ruggle come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Ruggle

Family Medicine · Newton, IANPI 1437187077

Payments from drug & device makers

$4,973in general payments, 2019–2025

Across 378 payments — averaging $13.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$811
Boehringer Ingelheim$459
Novo Nordisk$362
Sanofi-aventis U.S. LLC$324
Johnson & Johnson$298
Pfizer$272
plus $2K from 33 others

What the payments were for

Food & beverage$4,88398%
Education$902%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	85	$811
Boehringer Ingelheim	31	$459
Novo Nordisk	22	$362
Sanofi-aventis U.S. LLC	19	$324
Johnson & Johnson(2 entities)	24	$298
Pfizer	28	$272
Amgen	19	$260
Takeda Pharmaceuticals U.S.A., Inc.	20	$227
Novartis	17	$226
GSK	16	$220
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	10	$147
Abbott	7	$145
Bayer	7	$145
Sunovion Pharmaceuticals Inc.	12	$137
AstraZeneca	8	$122
Astellas Pharma US Inc	9	$120
Biohaven Pharmaceutical Holding Company Ltd.	4	$95
Lilly USA, LLC	6	$80
Teva Pharmaceuticals USA, Inc.	6	$77
Sanofi Pasteur Inc.	2	$53
Ironwood Pharmaceuticals, Inc	2	$38
Biohaven Pharmaceuticals, Inc.	2	$32
Daiichi Sankyo Inc.	2	$30
Therapeuticsmd, Inc.	2	$30
Medtronic	1	$25
E.r. Squibb & Sons, L.L.C.	2	$24
Kowa Pharmaceuticals America, Inc.	2	$23
Eisai Inc.	2	$23
Amarin Pharma, Inc.	1	$19
Xeris Pharmaceuticals, Inc.	1	$19
Exeltis, USA Inc.	1	$18
Agile Therapeutics, Inc.	1	$17
Regeneron Healthcare Solutions, Inc.	1	$16
Otsuka America Pharmaceutical, Inc.	1	$16
Esperion Therapeutics, Inc.	1	$15
Merck	1	$14
Hologic Sales And Service, LLC	1	$13
VBI Vaccine (delaware) Inc.	1	$11
Collegium Pharmaceutical, Inc.	1	$11

How this compares

$4,973 in reported general payments places this provider in the 90th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Atorvastatin Calcium	16	$184
Amlodipine Besylate	21	$95
Omeprazole	13	$59
Lisinopril	11	$51
Metformin Hcl	11	$22

Paid to pharmacies, not to this prescriber.

Other family medicine in Newton

Min PakNewton$11K
Mureema SolbergNewton$9K
Steven HillNewton$9K
Andrew CopeNewton$9K
Patrick EdwardsNewton$9K
Zacheriah AlexanderNewton$8K
Nicholas GoetschWaterloo$4.1M
James PoockWaterloo$1.5M
Jennifer KayCouncil Bluffs$613K
Nicholas BechtoldSioux City$584K

See the full list for Iowa →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →